Performance of a novel Viresolve NFR virus filter

Biotechnology Progress

Volumn 18, Issue 4, 2002, Pages 782-795

  Brough, Helene ^a,b   Antoniou, Chris ^a,b   Carter, Jeffrey ^a,b   Jakubik, Jocelyn ^a,b   Xu, Yuan ^a,b   Lutz, Herbert ^a,b  

^a MILLIPORE CORPORATION   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS FILTERS;

BACTERIA; CELLS; CONTAMINATION; MONOCLONAL ANTIBODIES; PROTEINS; VIRUSES;

BIOTECHNOLOGY;

ANIMAL; BACTERIA; BIOTECHNOLOGY; BUFFERS; CHO CELLS; DRUG CONTAMINATION; FILTRATION; HAMSTERS; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; PERMEABILITY; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN, BOVINE; SOLUTIONS; TIME FACTORS; VIRUSES; ANIMALS; CRICETINAE;

ACHOLEPLASMA; ACHOLEPLASMA LAIDLAWII; ADENOVIRIDAE; BACTERIA (MICROORGANISMS); BREVUNDIMONAS; BREVUNDIMONAS DIMINUTA; HUMAN ADENOVIRUS TYPE 2; MAMMALIA; MAMMALIAN ORTHOREOVIRUS 3; MURINAE; MURINE LEUKEMIA VIRUS; MYCOPLASMA; MYCOPLASMATALES; REOVIRUS SP.; UNIDENTIFIED RETROVIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

BOVINE SERUM ALBUMIN; BUFFER; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; BACTERIUM; BIOTECHNOLOGY; CHEMISTRY; CHO CELL; CLASSIFICATION; DRUG CONTAMINATION; EVALUATION; FILTRATION; HAMSTER; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; PARTICLE SIZE; PERMEABILITY; REPRODUCIBILITY; SOLUTION AND SOLUBILITY; TIME; VIRUS;

EID: 0036021996     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp010193+     Document Type: Article

References (55)

1. Detection by PCR of wild-type canine parvovirus which contaminates dog vaccine
2. Makers of blood products settle US HIV lawsuits
3. Baxter product hepatitis case may be linked
4. Government to pay for Irish Hepatitis C scandal
5. Hepatitis virus passed to hemophiliacs by clotting compound
6. Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirus
7. Sequence analysis of the 5′ untranslated region of pestivirus RNA demonstrated in interferons for human use
8. Experiences of virus, retrovirus and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for the production of protein therapeutics
9. Defective endogenous retrovirus-like sequences and particles of Chinese hamster ovary cells
10. Methods for estimating retroviral burden
11. Sequence organization of cloned intracisternal A particle genes
12. Retroviridae: The viruses and their replication
13. Type A and C virus particles in murine and other mammalian leukemias and sarcomas
14. Biological and molecular characterization of an endogenous retrovirus present in CHO/HBs-A Chinese hamster cell line
15. Mammalian cells in culture frequently release type C viruses
16. Endogenous retroviruses of continuous cell substrates
17. Cell bank characterization for recombinant DNA mammalian cell lines
18. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells
19. Characterization of recombinant monkey and human erythropoietin
20. Intracellular assembly and packaging of Hepatitis B surface antigen particles occur in the endoplasmic reticulum
21. Infectious C-type virus isolated from a baboon placenta
22. Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells
23. The pathogenic potential of endogenous retroviruses: Facts and fantasies
24. Retrovirus phylogeny and evolution
25. Evolutionary history of reverse transcriptase
26. Topic Q5A, Quality of biotechnological products: Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
27. Process development and regulatory approval of tissue type plasminogen activator
28. Viral safety of recombinant Factor IX
29. Surveillance of poliomyelitis in the United States in 1955
30. The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955
31. Microbial retention testing in the validation of sterilizing filtration
32. Methods used to validate microporous membranes for the removal of mycoplasma
33. Test for mycoplasma contamination of cultured cells as applied at the ATCC
34. Morphology of Ureaplasma urealyticum (T-mycoplasma) organisms and colonies
35. Bacteriophage π6: A lipid-containing virus of Pseudomonas phaseolicola
36. Properties of R Plasmid R772 and the corresponding pilus-specific phage PR772
37. Preliminary investigation of the phage πX174 crystal structure
38. The three-dimensional structure of reovirus obtained by cryo-electron microscopy
39. The icosahedral form of an adenovirus
40. Electrostatic effects on protein partitioning in size exclusion chromatography and membrane ultrafiltration
41. max testing for practical microfiltration train scale-up in biopharmaceutical processing
42. Detection of viruses in recombinant cells by electron microscopy